About Acucela

Acucela Inc. is a clinical stage biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glaucoma, significantly affect quality of life for over 50 million people worldwide, and there is a drastic lack of therapies available. Until – more... 

Claim this company page
Headquarters
Seattle Washington, United States
Revenue
$3 Million
Employees
51 to 200
Industry
Links
Acucela website